Let’s get into the changing dynamics of biotech and life sciences funding, examining the resurgence of IPOs, the role of non-dilutive funding, and the opportunities and challenges posed by SPACs. This session will explore strategies for navigating an increasingly competitive and volatile capital market to secure sustainable investments.
- Analyze trends in IPOs, SPACs, mega-financing rounds, and private capital markets for life sciences companies.
- Examine the growing role of non-dilutive funding sources, such as grants and government programs, in early-stage biotech development.
- Discuss strategies to attract venture and institutional investors while balancing alternative financing opportunities.
- Gain insights into timing, structuring, and executing successful exits or transformative funding strategies for biotech and pharma organizations
